Results 21 to 30 of about 39,959 (306)

Clinical case of atypical course of Crohn’s disease

open access: yesPatologìâ, 2023
Crohn’s disease (CD) is a chronic recurrent inflammatory bowel disease with a wide variety of clinical manifestations – from classical gastrointestinal phenotypes to predominance of extraintestinal symptoms.
L. V. Zhuravlyova   +5 more
doaj   +1 more source

Clinical and electrophysiological features of peripheral neuropathy in older patients with lung carcinoma [PDF]

open access: yesVojnosanitetski Pregled, 2020
Background/Aim. Peripheral nervous system affection in people with lung cancer is commonly associated with paraneoplastic neuropathy. However, clinical studies evaluating the frequency, clinical, and electrophysiological characteristics of peripheral ...
Tomanović-Vujadinović Sanja   +9 more
doaj   +1 more source

Pathological classification of equine recurrent laryngeal neuropathy [PDF]

open access: yes, 2018
Recurrent Laryngeal Neuropathy (RLN) is a highly prevalent and predominantly left‐sided, degenerative disorder of the recurrent laryngeal nerves (RLn) of tall horses, that causes inspiratory stridor at exercise because of intrinsic laryngeal muscle ...
Draper, A C E, Piercy, R J
core   +2 more sources

Acute polyneuropathy as the main manifestation of primary Sjogren’s syndrome: A case report

open access: yesClinical Case Reports, 2022
Sjogren's syndrome is an inflammatory disease affecting many systems. We report a Sjogren case with the presenting feature of an acute motor‐predominant polyneuropathy resembling Guillain–Barre syndrome.
Arsh Haj Mohamad Ebrahim Ketabforoush   +4 more
doaj   +1 more source

Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II). [PDF]

open access: yes, 2005
BACKGROUND: Treatment of late-stage human African trypanosomiasis (HAT) with melarsoprol can be improved by shortening the regimen. A previous trial demonstrated the safety and efficacy of a 10-day treatment schedule.
Asumu, P   +10 more
core   +2 more sources

DIABETIC POLYNEUROPATHY: PATHOGENESIS, CLINICAL PRESETATION AND NEW APPROACHES TO PERSONALIZED TREATMENT

open access: yesМедицинский совет, 2017
In summary, this review provides complex presentation of the most contemporary concepts of pathogenesis, clinical presentation and therapy of diabetic polyneuropathies.
M. M. Tanashyan   +2 more
doaj   +1 more source

Deciphering immune mechanisms in chronic inflammatory demyelinating polyneuropathies.

open access: yesJCI Insight, 2020
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an autoimmune disease of the peripheral nerves that presents with either chronic progression or relapsing disease.
Jolien Wolbert   +3 more
semanticscholar   +1 more source

Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies. [PDF]

open access: yes, 2018
Polyneuropathy with immunoglobulin M (IgM) monoclonal gammopathy is the most common paraproteinemic neuropathy, comprising a clinicopathologically and immunologically distinct entity.
Dalakas, Marinos
core   +2 more sources

Health-related quality of life in hereditary transthyretin amyloidosis polyneuropathy: a prospective, observational study [PDF]

open access: yes, 2020
Background Hereditary Transthyretin Amyloidosis Polyneuropathy is a rare life-threatening neurologic disease that imposes considerable mortality and it is associated with progressive related disabilities.
Coelho, Teresa   +5 more
core   +2 more sources

COVID-19 Associated Guillain–Barré Syndrome: A Report of Nine New Cases and a Review of the Literature

open access: yesMedicina, 2022
Background: Guillain–Barré syndrome (GBS)—a rare condition characterized by acute-onset immune-mediated polyneuropathy—has been registered as a neurological manifestation of COVID-19, suggesting a possible link between these two conditions.
Andreea Paula Ivan   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy